CDC Conference Shifts to Closed Doors: Public Access Ends After Decades

The U.S. Centers for Disease Control and Prevention (CDC) has quietly ended a decades-long tradition of open public access to its annual Epidemic Intelligence Service (EIS) Conference. For the first time in its history, the 2024 conference, held April 22–25 in Atlanta, was restricted to invited attendees only, excluding journalists, researchers, and the general public.

The decision marks a significant departure from the CDC’s long-standing policy of transparency, which allowed public participation and fostered collaboration across the public health community. The EIS Conference has historically served as a platform for presenting groundbreaking research, outbreak investigations, and innovative public health strategies.

What Changed and Why It Matters

According to internal communications obtained by STAT, the CDC cited "security concerns" as the primary reason for the shift. However, the move has sparked criticism from public health experts who argue that restricting access undermines the conference’s role in promoting transparency and accountability in disease prevention and response.

Dr. Tom Frieden, former CDC director and current president and CEO of Resolve to Save Lives, expressed concern over the decision. "The EIS Conference has always been a cornerstone of public health transparency," Frieden said. "Closing it to the public sets a dangerous precedent and could hinder collaboration at a time when global health security is more critical than ever."

Reactions from the Public Health Community

The sudden change has left many in the public health sector questioning the CDC’s motives. Historically, the EIS Conference has been a hub for sharing critical research on emerging infectious diseases, vaccine development, and health disparities. Past attendees have included epidemiologists, clinicians, policymakers, and journalists who relied on the conference to stay informed about the latest developments in public health.

Dr. Céline Gounder, an infectious disease specialist and editor-at-large for public health at KFF Health News, highlighted the importance of open access. "The EIS Conference has been a vital resource for journalists, researchers, and the public to understand the science behind disease outbreaks and prevention strategies," Gounder said. "Restricting access could limit the dissemination of crucial information and slow down our collective response to health threats."

Impact on Transparency and Collaboration

The decision to close the conference has raised broader questions about the CDC’s commitment to transparency. Public health advocates argue that restricting access to such a high-profile event could erode trust in the agency and hinder efforts to combat misinformation.

In a statement, the CDC defended the decision, emphasizing the need to "protect sensitive information" and ensure the safety of attendees. However, critics point out that the conference has never been a high-risk event in terms of security threats, and the move appears to be more about control than safety.

Historically, the EIS Conference has been a platform for discussing sensitive topics, including the origins of COVID-19, the opioid epidemic, and the impact of climate change on health. The lack of public access to these discussions could limit the public’s ability to hold officials accountable and understand the science behind critical health policies.

Looking Ahead: Will the CDC Reconsider?

As the public health community grapples with the implications of this decision, calls for the CDC to reverse course are growing. Advocates are urging the agency to reinstate public access to the EIS Conference, emphasizing the importance of transparency in safeguarding public health.

For now, the CDC has not indicated whether the closed-door policy will continue in future years. However, the shift has already sparked a broader debate about the balance between security and transparency in public health.